chr11-64810034-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001370259.2(MEN1):c.76G>A(p.Glu26Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 30)
Consequence
MEN1
NM_001370259.2 missense
NM_001370259.2 missense
Scores
8
8
3
Clinical Significance
Conservation
PhyloP100: 7.13
Genes affected
MEN1 (HGNC:7010): (menin 1) This gene encodes menin, a tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. Menin is a scaffold protein that functions in histone modification and epigenetic gene regulation. It is thought to regulate several pathways and processes by altering chromatin structure through the modification of histones. [provided by RefSeq, May 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), MEN1. . Trascript score misZ 4.1921 (greater than threshold 3.09). GenCC has associacion of gene with multiple endocrine neoplasia type 1, pituitary gigantism, familial isolated hyperparathyroidism.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.91
PP5
Variant 11-64810034-C-T is Pathogenic according to our data. Variant chr11-64810034-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 16689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64810034-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEN1 | NM_001370259.2 | c.76G>A | p.Glu26Lys | missense_variant | 2/10 | ENST00000450708.7 | NP_001357188.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEN1 | ENST00000450708.7 | c.76G>A | p.Glu26Lys | missense_variant | 2/10 | 5 | NM_001370259.2 | ENSP00000394933 | P3 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome Cov.: 35
GnomAD4 exome
Cov.:
35
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Multiple endocrine neoplasia, type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 28, 2023 | ClinVar contains an entry for this variant (Variation ID: 16689). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MEN1 protein function. This variant is also known as G186A (E26K). This missense change has been observed in individuals with multiple endocrine neoplasia type 1 (PMID: 9820618, 12016472, 20231234; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 26 of the MEN1 protein (p.Glu26Lys). - |
Parathyroid adenoma, somatic Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 1997 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2019 | Not observed in large population cohorts (Lek 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in patients with personal and/or family histories consistent with pathogenic variants in this gene referred for genetic testing at GeneDx and in published literature (Bartsch 1998, Langer 2002, Ellard 2005, Schaff 2007, Waldmann 2007, Schaefer 2008, White 2010); This variant is associated with the following publications: (PMID: 9241276, 9820618, 11114630, 15670192, 17853334, 17235589, 20231234, 30869828, 18426829, 12016472, 10730900) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;.;.;.;.;D;D;D;D;D;.;D;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;.;D;.;.;D;.;D;D;D;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;M;M;M;M;M;M;M;.;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D;D;D;D;D;D;T;T;T;D;D
Sift4G
Benign
T;T;T;T;T;T;T;T;T;.;T;T;.;.
Polyphen
1.0, 0.95, 0.96
.;D;P;P;P;D;D;D;D;.;.;.;.;.
Vest4
MutPred
Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);Gain of ubiquitination at E26 (P = 0.0238);
MVP
MPC
1.9
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at